Your World-Class Speaker Faculty

Take a closer look at the 100+ industry-renowned speakers headlining the 16th World Clinical Biomarkers & Companion Diagnostics Summit.

Pharmaceutical Leaders
Technology & AI Innovators
Transformative Charities, Associations & Academics
Biotech Pioneers
Leading Precision Medicine Solution Providers

Pharmaceutical Leaders

Amy Gorman

International Precision Medicine & Diagnostics Commercial Leader
AbbVie

Danielle Townsley

Executive Director & Precision Medicine Therapeutic Area Head, Oncology
Amgen

Diarmuid Moran

Head of Precision Medicine & Diagnostics (R&D)
Astellas Pharma

Mark Gustavson

Senior Director, Computational Pathology
AstraZeneca

Etai Jacob

Head, Applied Data Science & AI, Oncology R&D
AstraZeneca

John W. Longshore

Head, Scientific Affairs, Global Oncology Diagnostics
AstraZeneca

Adriana Racolta

Senior Director, Global Regulatory Leader, IVD
Bayer

Jon Baden

Executive Director & Head, Precision Medicine
Bristol Myers Squibb

Jilian Golding

Global Commercial Strategy, Precision Medicine Lead
Bristol Myers Squibb

Christina Bender

Director, Global Oncology Marketing, Biomarker Strategy
Daiichi Sankyo

Peter Krein

Vice President, Diagnostic Development
Eli Lilly & Co

Amy H. Kao

Senior Vice President, Global Head, Research Unit, & Neuroscience, Immunology & Billerica Campus Head
EMD Serono the Healthcare business of Merck KGaA

Zheng Feng

Director & Head, Clinical Genomics, Clinical Biomarker Technologies
EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany

Lauri Diehl

Executive Director, Research Pathology
Gilead Sciences

Cecilia Schott

Vice President & Head, Precision Diagnostics, Oncology Translational Medicine R&D
GSK

Mike Washburn

Executive Director & Head, Integrative Sciences, Oncology Translational Medicine
GSK

Angela Silvestro

Director, Companion Diagnostics
GSK

Andrea Stevens

Senior Director, Precision Medicine Access
Johnson & Johnson Innovative Medicine

Viraj Tyagi

Global Alliance Leader, Precision Medicine & Diagnostics
Johnson & Johnson Innovative Medicine

Neha Kumar

Global Commercial Lead, Precision Medicine Strategy
Johnson & Johnson Innovative Medicine

Fernando Cruz-Guilloty

Director, Oncology Precision Medicine & Diagnostics
Johnson & Johnson Innovative Medicine

Carol Peña

Associate Vice President, Companion Diagnostic Development
Merck

Sid Mathur

Executive Director, Regulatory Diagnostics & Digital Health (RDDH)
Merck

Karim Azer

Global Head, Data & AI, Clinical Development
Novartis

Nancy Krunic, Ph.D

Vice President & Precision Medicine Head, Diagnostic Sciences & Partnerships
Novartis

Wendy Valenius

Senior Manager, Global Regulatory Strategy, Companion Diagnostics Oncology
Pfizer

Benjamin Withey

Director, Commercial Diagnostics & Companion Diagnostics Lead
Pfizer

Lindsay Darling

Director, Clinical Laboratory & Diagnostic Delivery
Regeneron

Emanuele De Rinaldis

Vice President & Global Head, Target, Diseases & Systems Biology
Sanofi

Alina Ainbinder

Scientific Associate Director
Takeda

Technology & AI Innovators

Rowland Illing

Chief Medical Officer & Director, Healthcare & Life Sciences
Amazon Web Services (AWS)

David Henderson

Customer Engineer III AI/ML, Life Sciences North
Google Cloud

Alexander Mehmet Ersoy

Director, Industry Advisory, Healthcare & Life Sciences
Microsoft

Transformative Charities, Associations & Academics

Lauren Leiman

Executive Director
BLOODPAC

Caroline Koffke

Director, Educational & Healthcare Provider Programs
Living Beyond Breast Cancer

Lee Cooper

Associate Professor
Northwestern University

Haley Director

Board of Directors, Policy
Rare New England

Tasia Rechisky

Board of Directory, Secretary, Policy Co-Lead, Rare Disease Patient & Advocate
Rare New England

Jill Weimer

Senior Director, Therapeutic Development
Sanford Research

Jim Palma

Chief Executive Officer
TargetCancer Foundation

Marshall Thompson

Chief Technology Officer
The Rare Cancer Research Foundation

Matthew G.Hanna

Vice Chair, Pathology Informatics
University of Pittsburgh Medical Center

Biotech Pioneers

Chloe Delepine

Director, Clinical Biomarkers
Agenus

Shruti Gopal Vij

Director, Innovation & AI Strategy
Alexion Pharmaceuticals

Michael Stocum

President & Chief Executive Officer
Bantam Pharmaceutical

Priya S. Chockalingam

Vice President & Head, Clinical Bioanalytics & Translational Sciences
Beam Therapeutics

Francesca Barone

Chief Scientific Officer
Candel Therapeutics

Kris Sachsenmeier

Vice President, Translational Sciences
Compass Therapeutics

Jarema (Jarko) Kochan

Senior Director, Clinical Biomarkers & Clinical Development
Eikon Therapeutics

Katie Newhall

Executive Director, Translational Biomarkers & Diagnostics
Immunome

John Goldberg

Acting Chief Development Officer
Incendia Therapeutics

Jeff Jackson

Group Vice President, Translational Medicine
Incyte

Robin Edwards

Vice President, Translational Medicine
MacroGenics

Brian Tunquist

Senior Director, Translational Medicine
OnKure Therapeutics

Marla Weetall

Senior Vice President, Pharmacology & Biomarkers
PTC Therapeutics

Marsha Crochiere

Vice President, Translational Medicine & Research
Pyxis Oncology

David Chen

Senior Director, Precision Medicine & Companion Diagnostics
Revolution Medicines

Scott Yohe

Senior Vice President, Managed Markets & Access Strategy
Rigel Pharmaceutical

Marie Du

Executive Director, Biomarker & Translational Operations
Vanqua Bio

Leading Precision Medicine Solution Providers

Erin Grath

Associate Vice President, Regulatory Affairs
Agilent Technologies

Stewart McWilliams

Global Vice President, Quality & Regulatory Affairs
Almac Diagnostic Services

Matt Pink

Vice President, Business Development
Biodesix

Carla Kantara

Vice President & Head, Enterprise Partnering
Caris Life Sciences

Gulfem Guler

Vice President, Translational Research
ClearNote Health

Heather Cohen

Vice President, Precision Medicine & Biomarkers
Create Medicines

Matthew Maland

Director, Regulatory Affairs
EntroGen

Eric Fung

Senior Vice President, Clinical Development, Population Health & Biostatistics
GRAIL

Hosein Kouros-Mehr

Senior Vice President, R&D
Myriad Genetics

Hedi Ben Brahim

Chief Executive Officer
One Biosciences
2
Explore the New Agenda

Hear the latest imaging, multi-omics, single-cell and functional assays, enhanced by AI-driven digital biomarker strategies, enabling earlier and smarter treatment decisions for oncology, autoimmune, neurological, chronic and rare disease patients

View the Presentation & Speaker Line-Up
CDx Europe - Networking Page
Partner with Us

Position your solutions alongside leading biomarker, diagnostic and technology providers, to ensure your brand is front and center, and retain your place as the partner of choice in the ever-expanding precision medicine space

View Partnership Options
1
Join 850+ Specialist Experts

Be part of the liveliest Rx-Dx conversations with like-minded industry peers spanning a range of precision therapy modalities, and build high-value connections during dedicated networking sessions designed to foster collaborations

Register Now